As of 2026-03-31, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (31.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -961.6%.
The range of the Relative Valuation is (30.81) - (34.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 19.9x | 18.4x |
| Forward P/E multiples | 15.7x - 19.4x | 17.2x |
| Fair Price | (30.81) - (34.21) | (31.45) |
| Upside | -944.2% - -1037.1% | -961.6% |
| Date | P/E |